Literature DB >> 16251720

Cell surface-expressed moesin-like HDL/apoA-I binding protein promotes cholesterol efflux from human macrophages.

Akifumi Matsuyama1, Naohiko Sakai, Hisatoyo Hiraoka, Ken-ichi Hirano, Shizuya Yamashita.   

Abstract

HDL and its major component, apolipoprotein A-I (apoA-I), play a central role in reverse cholesterol transport. We recently reported the involvement of a glycosylphosphatidylinositol anchor (GPI anchor) in the binding of HDL and apoA-I on human macrophages, and purified an 80 kDa HDL/apoA-I binding protein. In the present study, we characterized the GPI-anchored HDL/apoA-I binding protein from macrophages. The HDL/apoA-I binding protein was purified from macrophages and digested with endopeptidase, and the resultant fragments were sequenced. Cholesterol efflux, flow cytometry, immunoblotting, and immunohistochemical analyses were performed to characterize the HDL/apoA-I binding protein. Two parts of seven amino acid sequences completely matched those of moesin. Flow cytometry, immunoblotting, and immunohistochemistry using anti-moesin antibody showed that the HDL/apoA-I binding protein was N-glycosylated and expressed on the cell surface. It was termed moesin-like protein. Treatment of macrophages with anti-moesin antibody blocked the binding of HDL/apoA-I and suppressed cholesterol efflux. The moesin-like protein was exclusively expressed on macrophages and was upregulated by cholesterol loading and cell differentiation. Our results indicate that the moesin-like HDL/apoA-I binding protein is specifically expressed on the surface of human macrophages and promotes cholesterol efflux from macrophages.-Matsuyama, A, N. Sakai, H. Hiraoka, K-i. Hirano, and S. Yamashita. Cell surface-expressed moesin-like HDL/apoA-I binding protein promotes cholesterol efflux from human macrophages.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16251720     DOI: 10.1194/jlr.M500425-JLR200

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  2 in total

1.  Lipid-free apolipoprotein A-I exerts an antioxidative role against cell-free hemoglobin.

Authors:  Ruijuan Du; Imelda Winarsih; Bow Ho; Jeak Ling Ding
Journal:  Am J Clin Exp Immunol       Date:  2012-05-30

2.  Efficacy of a recombinant single-chain fragment variable region, VasSF, as a new drug for vasculitis.

Authors:  Yosuke Kameoka; Fukuko Kishi; Minako Koura; Yoshio Yamakawa; Rora Nagasawa; Fuyu Ito; Junichiro Matsuda; Osamu Suzuki; Toshinori Nakayama; Kazuo Suzuki
Journal:  Drug Des Devel Ther       Date:  2019-02-05       Impact factor: 4.162

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.